Compare CADL & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CADL | SPIR |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.4M | 533.0M |
| IPO Year | 2021 | 2020 |
| Metric | CADL | SPIR |
|---|---|---|
| Price | $5.10 | $20.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $19.00 | $15.80 |
| AVG Volume (30 Days) | 1.1M | ★ 1.9M |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 58.62 | ★ 134.98 |
| EPS | N/A | ★ 1.49 |
| Revenue | $125,000.00 | ★ $110,451,000.00 |
| Revenue This Year | N/A | $11.91 |
| Revenue Next Year | N/A | $23.34 |
| P/E Ratio | ★ N/A | $15.46 |
| Revenue Growth | N/A | ★ 13.15 |
| 52 Week Low | $4.34 | $6.60 |
| 52 Week High | $7.24 | $23.59 |
| Indicator | CADL | SPIR |
|---|---|---|
| Relative Strength Index (RSI) | 52.99 | 67.70 |
| Support Level | $4.57 | $8.28 |
| Resistance Level | $5.25 | N/A |
| Average True Range (ATR) | 0.23 | 2.12 |
| MACD | 0.03 | 0.83 |
| Stochastic Oscillator | 84.97 | 77.61 |
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.